Current initiatives

CAMP is a Vinnova funded project focussing on the science and technology required to translate ATMPs from lab to clinic, including bioprocess development, GMP production and logistics.

SWECARNET is Sweden’s network for clinical use of CAR T cells and was established in 2019 by the SDP5 Swelife-ATMP project of the same name.

The project aims to establish a ’Vision Driven Innovation Milieu’ for long-term transformation of the systems required for successful development and implementation of advanced therapy gene and cell therapeutic products, Advanced Therapy Medicinal Products (ATMP).